Featured Post from ChristianaCare

Nurse Scientist Susan Smith Birkhoff Makes Two Research ‘Firsts’ in Delaware

Innovative researcher named to leadership role in DE-INBRE and recognized for mentoring

Mar 17, 2025

3 min

Susan Smith, Ph.D, RNOmar A. Khan, M.D., MHS, FAAFP

Susan Smith Birkhoff, Ph.D., RN, is making nursing history in the First State through the Delaware IDeA Network of Biomedical Research Excellence (INBRE). She is the first nurse scientist to be named an INBRE site principal investigator and she is the first nurse to receive the Seema S. Sonnad Mentor of the Year Award from INBRE’s Junior Investigator Network.


INBRE is a collaborative network of Delaware academic, health care and research institutions, composed of ChristianaCare, Delaware State University, Delaware Technical Community College Nemours Children’s Health and University of Delaware.


First nurse scientist to lead INBRE site

CaptionResizeWrap TextRemove


As the INBRE site principal investigator at ChristianaCare, Smith Birkhoff will expand on the research network’s success at a large academic health center. In collaboration with the INBRE partners and the program manager, Kellie Patterson, BSN, RN, CCRP, she will leverage centers of excellence across ChristianaCare to host an exceptional student program, increase the health system's contributions to the pilot program pool and grow the visibility of INBRE across the enterprise.


“Susan brings a terrific combination of skills to this role,” said Omar Khan, M.D., MHS, FAAFP, chief scientific officer for ChristianaCare and institutional representative on the INBRE steering committee.


“She is a mentor, scientist and teacher, and her experience with INBRE and the state’s other premier research programs will ensure that we deliver the highest value for the Delaware community.”


Smith Birkhoff leads and supports interprofessional research education, systemwide technology evaluation, and grantsmanship. She spearheads a diverse research program, encompassing areas such as robotics in health care, virtual reality in medicine and burnout in the nursing workforce.


As program director of Technology Research & Education at ChristianaCare, she collaborates across the health system’s academic research enterprise to achieve both clinician- and patient-oriented research outcomes.


“Susan is a wonderful colleague and she is a true researcher-educator,” said Neil Jasani, M.D., MBA, FACEP, chief academic officer for ChristianaCare. “She is a great fit for the work of Delaware INBRE as we advance ChristianaCare’s contribution to this essential research network.”


She co-leads an innovative program to study the one of the first deployments of increasingly autonomous robots in a U.S. health care setting and directs the first Nursing Research Fellowship in Robotics and Innovation, housed at ChristianaCare.


First nurse named Mentor of the Year


Smith Birkhoff received the 2025 Seema S. Sonnad Mentor of the Year Award from INBRE’s Junior Investigator Network, nominated for her exceptional mentorship by ChristianaCare colleagues whom she mentored. Her nominators were: Kaci Rainey, MSN, RN, CEN, TCRN, an evidence-based practice specialist at ChristianaCare, and Briana Abernathy, BSN, RN, CEN, a nurse in utilization management at ChristianaCare and an inaugral nurse fellow in the Nursing Research Fellowship in Robotics and Innovation.


“They say that if you are not at the table, you are on the menu. We are profoundly grateful that Dr. Smith Birkhoff selflessly provided us with a seat at the table and an overflowing feast of knowledge,” said Abernathy in presenting the award.


“This knowledge has quenched our thirst for change and fueled our hunger for research and innovation, setting the stage for the rest of our careers.”

Connect with:
Susan Smith, Ph.D, RN

Susan Smith, Ph.D, RN

Program Director of Technology Research & Education

Susan Smith is a nurse scientist with experience conducting clinical research using various forms of digital health technology.

TechnologyInnovationResearchNursingRobotics
Omar A. Khan, M.D., MHS, FAAFP

Omar A. Khan, M.D., MHS, FAAFP

Enterprise Chief Scientific Officer

Dr. Omar Khan is the enterprise chief scientific officer and vice president of research administration and scientific affairs.

Global HealthMedical EducationPublic HealthMedical Writing‎Healthcare Leadership
Powered by

You might also like...

Check out some other posts from ChristianaCare

A prescription for good health featured image

2 min

A prescription for good health

As more health systems, policymakers and insurers recognize the role of nutrition in preventing and managing disease, Michelle Axe is working to make Food Is Medicine a standard part of health care. Axe, manager of Food Is Medicine programs at ChristianaCare, oversees initiatives that connect patients with healthy food, nutrition education, health coaching and community-based support as part of their care plans. Her team addresses food insecurity while improving outcomes for people living with chronic disease, pregnant women and other populations facing health-related nutrition challenges. Axe works with clinicians, dietitians, health coaches, community health workers and community partners to provide medically tailored meals, medically tailored groceries, produce prescriptions and nutrition education. These interventions embed nutritious food into treatment, alongside traditional medical care. Healthier Meals, Better Outcomes When patients have access to nourishing food, they’re more likely to keep their conditions under control and avoid complications. Better nutrition can support lower blood sugar, improved blood pressure and overall improved wellness. Food support can also reduce the need for emergency visits and hospital stays, improving health outcomes in meaningful ways beyond filling a plate. Outside of ChristianaCare, Axe plays a key role in statewide conversations about how Delaware can advance Food Is Medicine strategies. She serves as co-chair of the Delaware Food Is Medicine Funding, Policy and Sustainability Working Group, alongside Delaware’s deputy secretary for Medicaid, placing her at the center of discussions about policy, community partnerships and the future of nutrition-focused health care in Delaware. Axe can provide on-the-ground insight into what it takes to move nutrition interventions from theory to practice and how health systems can measure their impact on patients and communities. Topics Axe can discuss include: • Why health systems are increasingly prescribing food alongside traditional treatments. • The connection between food insecurity, chronic disease and rising health care costs. • Can medically tailored meals reduce hospitalizations and improve outcomes? • How Food Is Medicine programs are supporting healthier pregnancies and families. • What it takes to scale Food Is Medicine from pilot projects to sustainable health care programs.

ChristianaCare, Lisen Imprinting Diagnostics Launch Research Collaboration to Improve Lung Cancer Diagnosis featured image

3 min

ChristianaCare, Lisen Imprinting Diagnostics Launch Research Collaboration to Improve Lung Cancer Diagnosis

Researchers at ChristianaCare and Delaware-based Lisen Imprinting Diagnostics (LisenID) are launching a study to validate a technology designed to detect one of the earliest molecular markers linked to lung cancer development, potentially helping physicians find answers when biopsy results are unclear. The collaboration, led by ChristianaCare’s Cawley Center for Translational Cancer Research, will evaluate LisenID’s QCIGISH (Quantitative Chromogenic Imprinted Gene In-Situ Hybridization) diagnostic platform in patients enrolled in ChristianaCare’s lung cancer screening and diagnostics program. Researchers will validate whether the technology can identify early molecular changes linked to cancer in tissue samples before those changes are visible on pathology under a microscope, potentially adding useful information when biopsy results are inconclusive. Lung cancer remains the leading cause of cancer death in Delaware and across the United States. Survival is much higher when the disease is found early, which has increased interest in tools that may help improve the speed and accuracy of diagnosis. Addressing a common challenge in cancer diagnosis As cancer screening technology evolves, earlier and smaller lesions are found that clinicians must confidently and accurately diagnose. In about 20% of cases, a lung biopsy does not provide enough information to confirm or rule out cancer. Other times, the tissue sample is limited or the results are unclear, leading to repeat testing, months of delay to diagnosis and worse patient outcomes. Traditional pathology relies on examining cells under a microscope. LisenID’s technology is designed to detect early molecular changes in biopsy samples linked to cancer that may not yet be visible through standard methods. Researchers will evaluate whether this technology can help in difficult diagnostic cases. “Advances in cancer care depend on evaluating new approaches that may improve diagnosis,” said Thomas Schwaab, M.D., Ph.D., Bank of America Endowed Medical Director of ChristianaCare’s Helen F. Graham Cancer Center & Research Institute. “This collaboration brings together clinicians and researchers to study a technology that could help reduce uncertainty for patients and support better decisions in challenging cases.” Bringing research to patient care The project brings together specialists from ChristianaCare’s Helen F. Graham Cancer Center & Research Institute, including thoracic surgeons, interventional pulmonologists and cancer researchers. The clinical effort is being led by Brian Nam, M.D., chief of Thoracic Surgery and Interventional Pulmonary. “One of the most difficult situations for patients is when a biopsy does not give a clear answer,” Nam said. “We may not have enough tissue or the results may be unclear. We are evaluating whether this technology can provide additional information that helps guide next steps and reduce uncertainty.” Jennifer Sims-Mourtada, Ph.D., associate director of the Cawley Center for Translational Cancer Research, said the study reflects the center’s focus on moving promising discoveries into clinical testing. “Our role is to rigorously evaluate new approaches in a clinical setting,” Sims-Mourtada said. “This technology has shown promise in published research and through collaborations with leading institutions. We are now working to determine whether it can provide meaningful information that supports better clinical decisions.” Building on prior research The collaboration builds on prior research involving the technology. LisenID reports its platform has been built on research on more than 10,000 clinical cases through collaborations with hospitals and medical centers in the United States and Internationally. Research published in peer-reviewed journals, including the Journal of Clinical Oncology and Clinical Epigenetics, has suggested that early molecular changes in gene activity may help identify early lung cancer and evaluate small pulmonary nodules. Last year, LisenID also announced a research collaboration with Mayo Clinic focused on advancing applications of its technology in cancer diagnosis. The company was recognized as one of the top graduates of the 2026 Creative Destruction Lab Cancer Stream, a highly selective international accelerator for science-based startups. Tina Cheng, M.D., co-founder of LisenID, said the collaboration will help evaluate the technology in real-world clinical settings. “Some of the earliest changes in cancer occur at a molecular level before they can be seen under a microscope,” Cheng said. “Our goal is to validate the applicability of our test in clinical cases to see how the test can help physicians when standard testing does not provide clear answers.” The collaboration highlights growing ties between Delaware’s health care and biotechnology communities. By combining ChristianaCare’s cancer expertise with LisenID’s diagnostic technology, the organizations aim to improve tools that may help physicians diagnose lung cancer more accurately and earlier.

ChristianaCare Expands Access to Physical Therapy With New In Home Collaboration With Luna featured image

3 min

ChristianaCare Expands Access to Physical Therapy With New In Home Collaboration With Luna

ChristianaCare is joining forces with Luna, the leading provider of in home, in person outpatient physical therapy, to expand access to care by bringing hands on physical therapy directly into patients’ homes. The new service, ChristianaCare Physical Therapy At Home, Powered by Luna, will begin taking appointments in June. The collaboration is designed to reduce barriers to care, support strong recovery outcomes and give patients a convenient way to begin physical therapy. Care Delivered Where Patients Need It Most Unlike remote or virtual therapy, the service will provide one on one, hands on care delivered by licensed physical therapists in the convenience of a patient’s home or office. Through Luna’s platform, patients can request care and are matched with a licensed physical therapist who delivers 45 to 55 minute in home sessions and continues in person care throughout the patient’s treatment plan. “Our collaboration with Luna reflects a simple belief: if we can safely deliver high quality care in the home, we should make that option available,” said Jennifer Thomas, MBA, MS, vice president, Rehabilitation Services at ChristianaCare. “By meeting patients where they are, we remove common barriers to care and help people stay engaged in their recovery, regain independence and remain connected to daily life.” Designed to Help More Patients Get Started Too many people who are referred to physical therapy never take the first step. Research on patients referred to physical therapy has found that only about 50% to 76% attend an initial appointment. Travel challenges, scheduling conflicts and difficulty accessing care can all get in the way. ChristianaCare Physical Therapy At Home, Powered by Luna, is designed to make it easier for patients to begin care without delay by bringing licensed physical therapists directly to them and offering scheduling that fits into daily life. “Our focus is on timely access and helping patients get started,” Thomas said. “When care is easier to access and fits into a person’s routine, it is much more likely they will begin treatment. From there, our care teams support patients through a plan that is tailored to their needs and focused on meaningful recovery.” Different From Home Health Care ChristianaCare Physical Therapy At Home, Powered by Luna, follows an outpatient care model, not home health care. Patients do not need to be homebound to receive services. The program focuses on improving strength, balance and movement and is typically covered under Medicare Part B. This differs from home health care, which serves homebound patients who need short term medical services and is usually covered under Medicare Part A. ChristianaCare Physical Therapy At Home, Powered by Luna, can address many of the conditions commonly treated by ChristianaCare Rehabilitation Services, including orthopedic and sports injuries, post surgical rehabilitation, geriatric care, vestibular therapy, women’s health and lymphedema. Experienced Partner With Broad Clinical Expertise Luna has extensive experience delivering in home outpatient physical therapy and partners with health systems nationwide. “We are proud to work with ChristianaCare to expand access to high quality physical therapy in the home,” said Lily Beltran, co-founder and President at Luna. “Our shared focus is on removing barriers to care and delivering consistent, hands on therapy that helps patients recover, stay engaged and achieve their goals.” The service is covered by most major insurance plans, including Medicare, with the same co pay as facility based physical therapy. Patients can request in home care by calling ChristianaCare Rehab Services’ access center at 302-623-1500. ChristianaCare Physical Therapy At Home, Powered by Luna is a service offering of ChristianaCare Rehabilitation Services, which provides comprehensive, patient centered rehabilitation care across a wide range of settings, including outpatient clinics, inpatient facilities, community locations and now in the home.

View all posts
Powered by